Daily non-political popular news in brief.

Stem cell transplants explored at Stanford as a possible treatment for hearing loss

02-17-2007 · EurekAlert!

As a leader in stem cell-based research on the inner ear at the Stanford University School of Medicine, he's got a step-by-step plan for making this dream a reality.

Keywords: stem, cell, transplants, explored, stanford, possible, treatment, hearing, loss, transplant

« Previous | Next »

Similar news on "Stem cell transplants explored at Stanford as a possible treatment for hearing loss":

A faster way to recover from chemotherapy and marrow transplant
06-20-2007 · EurekAlert!
Researchers at Children's Hospital Boston report finding a practical way to increase stem cells in blood, suggesting a possible treatment to help patients recover from chemotherapy or bone marrow transplant for cancer, regaining immune function more quickly. The discovery, reported in the June 21 Nature and made possible through high-volume drug screening in fish, marks the first time stem-cell production has been induced by a small-molecule drug.
Similar news · Read more »
First human trial tests stem-cell-based treatment for heart attacks
03-25-2007 · EurekAlert!
Previous research on the efficacy of stem cell therapy for heart repair has shown possible benefit from mesenchymal stem cells (MSCs) -- cells found in bone marrow that create connective tissue, bone and cartilage. A study presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit reveals the results of the first human trial using MSCs for the treatment of myocardial infarction (MI, or heart attack).
Similar news · Read more »
Can you hear me now? Stem cells enhance hearing recovery
06-25-2007 · EurekAlert!
Researchers have shown that bone marrow stem cells injected into a damaged inner ear can speed hearing recovery after partial hearing loss. The related report by Kamiya et al, "Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes," appears in the July issue of The American Journal of Pathology.
Similar news · Read more »
High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer
12-13-2007 · EurekAlert!
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at the University of Texas M. D. Anderson Cancer Center.
Similar news · Read more »
African-Americans receive fewer stem cell transplants than whites
02-08-2007 · EurekAlert!
African-Americans are less likely to receive potentially life-saving stem cell transplants than Caucasians, no matter whether the cells are from an anonymous donor, a relative or are self-donated, according to research being presented here at the 2007 BMT Tandem Meetings of the American Society for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research.
Similar news · Read more »
New drug therapy to combat GVHD in stem-cell patients shows significant reduction in deaths
01-23-2007 · EurekAlert!
Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
Similar news · Read more »
Stem cell transplant can grow new immune system in certain mice, Stanford researchers find
11-22-2007 · EurekAlert!
Researchers at the Stanford University School of Medicine have taken a small but significant step, in mouse studies, toward the goal of transplanting adult stem cells to create a new immune system for people with autoimmune or genetic blood diseases.
Similar news · Read more »
Tumor-reactive T cells boosted by hematopoietic stem cell transplantation
02-01-2007 · EurekAlert!
Treatment for skin cancer by infusion of tumor-reactive T cells requires patients to be pre-treated with agents that transiently decrease the number of immune cells (nonmyeloablative agents). A study in mice now indicates that pre-treatment with more intense immune cell-depleting strategies (known as myeloablative strategies) and a hematopoietic stem cell transplant enables infused tumor-reactive CD8+ T cells to increase in number more than pre-treatment with nonmyeloablative agents, and this correlates with increased tumor regression.
Similar news · Read more »
Stem cell procedure successfully treats amyloidosis patients
07-03-2007 · EurekAlert!
Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that tandem cycles of high-dose chemotherapy and blood stem cell transplantation can help treat patients with immunoglobulin-light chain (AL) Amyloidosis who did not respond to initial treatment with this method.
Similar news · Read more »
Study shows isolation of stem cells may lead to a treatment for hearing loss
04-05-2007 · EurekAlert!
Members of the National Center for Regenerative Medicine research team, Dr. Robert Miller and Dr. Kumar Alagramam, both of Case Western Reserve University School of Medicine, published research findings in Developmental Neuroscience which suggest new ways of treating hearing loss. These researchers have isolated "cochlear stem cells" located in the inner ear and already primed for development into ear-related tissue due to their proximity to the ear and expression of certain genes necessary for the development of hearing.
Similar news · Read more »